Sharon Tonner
MA, PhD
Study Project Manager
I joined the department in 2015 as a member of the ARCHIE (The early use of Antibiotics for At Risk CHildren with InfluEza in Primary Care) team and additionally supported the conduct and management of many other trials while based at the Clinical Trials Unit including PRINCIPLE and CONDUCT.
I am now based within the Cancer Research Group where my role is to facilitate the smooth running of studies conducted by the group and their collaborators.
Prior to moving to Oxford I worked at Glasgow and Edinburgh Universities and Kings College London on a wide range of study designs and disease areas.
Recent publications
-
Quality of life, healthcare use and costs in at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: Within-trial descriptive economic analyses of the ARCHIE randomised controlled trial
Journal article
Rombach I. et al, (2022), BMJ Open, 12
-
Urine collection devices to reduce contamination in urine samples for diagnosis of uncomplicated UTI: A single-blind randomised controlled trial in primary care
Journal article
Hayward G. et al, (2022), British Journal of General Practice, 72, 1 - 9
-
The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): A double-blind randomised placebo-controlled trial
Journal article
Wang K. et al, (2021), European Respiratory Journal, 58
-
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Butler CC. et al, (2021), The Lancet Respiratory Medicine, 9, 1010 - 1020
-
Platform Randomised trial of INterventions against COVID-19 in older peoPLE (PRINCIPLE): Protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
Journal article
Hayward G. et al, (2021), BMJ Open, 11